Deceased donor availability has substantially increased for patients with low MELD-Na, yielding graft survival comparable to LDLT. Further expansion of DCD LT could lower reliance on LDLT, thereby minimizing risks to healthy donors.
Nakayama et al. (Sun,) studied this question.